Veterinary Medicines

TEROVAXEC

Suspended
  • Clostridium perfringens, type B and C, beta toxoid
  • Clostridium perfringens, type B and D, epsilon toxoid
  • Clostridium septicum, toxoid
Download as PDF

Product identification

Medicine name:
TEROVAXEC
Active substance:
  • Clostridium perfringens, type B and C, beta toxoid
  • Clostridium perfringens, type B and D, epsilon toxoid
  • Clostridium septicum, toxoid
Target species:
  • Sheep
  • Goat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium perfringens, type B and C, beta toxoid
    10.00
    Toxic unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, type B and D, epsilon toxoid
    5.00
    Toxic unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium septicum, toxoid
    2.50
    Toxic unit(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep
      • Meat and offal
        0
        day
    • Goat
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI03AB
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Suspended
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Aquatreck Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cz Veterinaria S.A.
Responsible authority:
  • (AEMPS)
Authorisation number:
  • 3003 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."